236 related articles for article (PubMed ID: 38397133)
1. Large Deletions, Cleavage of the Telomeric Repeat Sequence, and Reverse Transcriptase-Mediated DNA Damage Response Associated with Long Interspersed Element-1 ORF2p Enzymatic Activities.
Kines KJ; Sokolowski M; DeFreece C; Shareef A; deHaro DL; Belancio VP
Genes (Basel); 2024 Jan; 15(2):. PubMed ID: 38397133
[TBL] [Abstract][Full Text] [Related]
2. Identification of L1 ORF2p sequence important to retrotransposition using Bipartile Alu retrotransposition (BAR).
Christian CM; deHaro D; Kines KJ; Sokolowski M; Belancio VP
Nucleic Acids Res; 2016 Jun; 44(10):4818-34. PubMed ID: 27095191
[TBL] [Abstract][Full Text] [Related]
3. Endonuclease-independent LINE-1 retrotransposition at mammalian telomeres.
Morrish TA; Garcia-Perez JL; Stamato TD; Taccioli GE; Sekiguchi J; Moran JV
Nature; 2007 Mar; 446(7132):208-12. PubMed ID: 17344853
[TBL] [Abstract][Full Text] [Related]
4. Similarities between long interspersed element-1 (LINE-1) reverse transcriptase and telomerase.
Kopera HC; Moldovan JB; Morrish TA; Garcia-Perez JL; Moran JV
Proc Natl Acad Sci U S A; 2011 Dec; 108(51):20345-50. PubMed ID: 21940498
[TBL] [Abstract][Full Text] [Related]
5. Structures, functions and adaptations of the human LINE-1 ORF2 protein.
Baldwin ET; van Eeuwen T; Hoyos D; Zalevsky A; Tchesnokov EP; Sánchez R; Miller BD; Di Stefano LH; Ruiz FX; Hancock M; Işik E; Mendez-Dorantes C; Walpole T; Nichols C; Wan P; Riento K; Halls-Kass R; Augustin M; Lammens A; Jestel A; Upla P; Xibinaku K; Congreve S; Hennink M; Rogala KB; Schneider AM; Fairman JE; Christensen SM; Desrosiers B; Bisacchi GS; Saunders OL; Hafeez N; Miao W; Kapeller R; Zaller DM; Sali A; Weichenrieder O; Burns KH; Götte M; Rout MP; Arnold E; Greenbaum BD; Romero DL; LaCava J; Taylor MS
Nature; 2024 Feb; 626(7997):194-206. PubMed ID: 38096902
[TBL] [Abstract][Full Text] [Related]
6. Involvement of Conserved Amino Acids in the C-Terminal Region of LINE-1 ORF2p in Retrotransposition.
Christian CM; Sokolowski M; deHaro D; Kines KJ; Belancio VP
Genetics; 2017 Mar; 205(3):1139-1149. PubMed ID: 28100588
[TBL] [Abstract][Full Text] [Related]
7. Cis-preferential LINE-1 reverse transcriptase activity in ribonucleoprotein particles.
Kulpa DA; Moran JV
Nat Struct Mol Biol; 2006 Jul; 13(7):655-60. PubMed ID: 16783376
[TBL] [Abstract][Full Text] [Related]
8. Effect of reverse transcriptase inhibitors on LINE-1 and Ty1 reverse transcriptase activities and on LINE-1 retrotransposition.
Dai L; Huang Q; Boeke JD
BMC Biochem; 2011 May; 12():18. PubMed ID: 21545744
[TBL] [Abstract][Full Text] [Related]
9. Evolutionary conservation of the functional modularity of primate and murine LINE-1 elements.
Wagstaff BJ; Barnerssoi M; Roy-Engel AM
PLoS One; 2011 May; 6(5):e19672. PubMed ID: 21572950
[TBL] [Abstract][Full Text] [Related]
10. Template and target-site recognition by human LINE-1 in retrotransposition.
Thawani A; Ariza AJF; Nogales E; Collins K
Nature; 2024 Feb; 626(7997):186-193. PubMed ID: 38096901
[TBL] [Abstract][Full Text] [Related]
11. Characterization of LINE-1 ribonucleoprotein particles.
Doucet AJ; Hulme AE; Sahinovic E; Kulpa DA; Moldovan JB; Kopera HC; Athanikar JN; Hasnaoui M; Bucheton A; Moran JV; Gilbert N
PLoS Genet; 2010 Oct; 6(10):. PubMed ID: 20949108
[TBL] [Abstract][Full Text] [Related]
12. Potential for genomic instability associated with retrotranspositionally-incompetent L1 loci.
Kines KJ; Sokolowski M; deHaro DL; Christian CM; Belancio VP
Nucleic Acids Res; 2014; 42(16):10488-502. PubMed ID: 25143528
[TBL] [Abstract][Full Text] [Related]
13. Evaluating different DNA binding domains to modulate L1 ORF2p-driven site-specific retrotransposition events in human cells.
Ade CM; Derbes RS; Wagstaff BJ; Linker SB; White TB; Deharo D; Belancio VP; Ivics Z; Roy-Engel AM
Gene; 2018 Feb; 642():188-198. PubMed ID: 29154869
[TBL] [Abstract][Full Text] [Related]
14. A potential role for the nucleolus in L1 retrotransposition.
Goodier JL; Ostertag EM; Engleka KA; Seleme MC; Kazazian HH
Hum Mol Genet; 2004 May; 13(10):1041-8. PubMed ID: 15028673
[TBL] [Abstract][Full Text] [Related]
15. Enrichment of processed pseudogene transcripts in L1-ribonucleoprotein particles.
Mandal PK; Ewing AD; Hancks DC; Kazazian HH
Hum Mol Genet; 2013 Sep; 22(18):3730-48. PubMed ID: 23696454
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of LINE-1 retrotransposon expression and its subcellular localization in breast cancer.
Chen L; Dahlstrom JE; Chandra A; Board P; Rangasamy D
Breast Cancer Res Treat; 2012 Nov; 136(1):129-42. PubMed ID: 23053642
[TBL] [Abstract][Full Text] [Related]
17. Molecular reconstruction of extinct LINE-1 elements and their interaction with nonautonomous elements.
Wagstaff BJ; Kroutter EN; Derbes RS; Belancio VP; Roy-Engel AM
Mol Biol Evol; 2013 Jan; 30(1):88-99. PubMed ID: 22918960
[TBL] [Abstract][Full Text] [Related]
18. Insights into LINE-1 reverse transcription guide therapy development.
Zehrbach NM; Oh N; Ishak CA
Trends Cancer; 2024 Apr; 10(4):286-288. PubMed ID: 38499453
[TBL] [Abstract][Full Text] [Related]
19. The Nucleotide Excision Repair Pathway Limits L1 Retrotransposition.
Servant G; Streva VA; Derbes RS; Wijetunge MI; Neeland M; White TB; Belancio VP; Roy-Engel AM; Deininger PL
Genetics; 2017 Jan; 205(1):139-153. PubMed ID: 28049704
[TBL] [Abstract][Full Text] [Related]
20. The endonuclease domain of the LINE-1 ORF2 protein can tolerate multiple mutations.
Kines KJ; Sokolowski M; deHaro DL; Christian CM; Baddoo M; Smither ME; Belancio VP
Mob DNA; 2016; 7():8. PubMed ID: 27099633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
